Dozens of autoimmune conditions can trigger uveitis, but a handful account for the majority of cases. In one large retrospective study, roughly 28% of all uveitis patients had a confirmed systemic autoimmune disease driving their eye inflammation.1PubMed Central. Characterizing autoimmune uveitis to systemic diseases: a retrospective study from a Syrian tertiary reference center The diseases most commonly responsible include spondyloarthropathies like ankylosing spondylitis, juvenile idiopathic arthritis, sarcoidosis, Behçet’s disease, and inflammatory bowel disease, though the list extends well beyond those. Understanding which diseases are involved, and how they present in the eye, matters because the uveitis itself is sometimes the first sign that a systemic condition is brewing.
Spondyloarthropathies and HLA-B27
The single strongest autoimmune association with uveitis involves a group of inflammatory joint diseases collectively called spondyloarthropathies. Ankylosing spondylitis is the most prominent member, but psoriatic arthritis, reactive arthritis, and arthritis linked to inflammatory bowel disease also belong to this family. What ties them together genetically is the HLA-B27 molecule, and the link between that gene and uveitis is among the most reproducible findings in the field. Most people with HLA-B27-associated uveitis will have an underlying spondyloarthropathy.2PubMed Central. Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders
The uveitis in these patients tends to be anterior, meaning it hits the front of the eye, particularly the iris. It often strikes one eye at a time, comes on suddenly with redness, pain, and light sensitivity, and then resolves over weeks with treatment. But it recurs. People with ankylosing spondylitis can experience dozens of flares over their lifetimes, and each one carries a small risk of lasting damage. Large genetic studies confirm that this type of uveitis shares overlapping susceptibility genes with the spondyloarthropathies and with inflammatory bowel disease, reinforcing the idea that these conditions are branches of the same immune dysfunction.3PubMed Central. Recent Developments in HLA B27 Anterior Uveitis
Juvenile Idiopathic Arthritis
In children, juvenile idiopathic arthritis is the leading autoimmune cause of uveitis. About one in ten children with JIA develops uveitis, and it overwhelmingly affects young girls, who make up 75 to 80% of cases. Antinuclear antibodies are positive in the vast majority of these patients. The risk to sight is highest when the arthritis begins during the preschool years.4PubMed Central. Uveitis in juvenile idiopathic arthritis
What makes JIA-associated uveitis especially dangerous is that it’s often painless and produces no obvious redness. A child can have smoldering inflammation in the eye for months before anyone notices, and by the time parents spot a problem, complications like cataracts, glaucoma, or band-shaped calcium deposits on the cornea may already be present.5PubMed Central. Management Strategies of Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis: Current Perspectives This is why every child diagnosed with JIA should start getting routine eye exams with a slit lamp immediately, regardless of whether they have any eye complaints. Early detection and treatment have dramatically reduced the rate of serious vision loss over the past two decades.
Sarcoidosis
Sarcoidosis is a granulomatous disease, meaning the immune system forms tiny clusters of inflammatory cells called granulomas in affected organs. The lungs and lymph nodes are the most common targets, but the eyes are hit frequently. Sarcoidosis-related uveitis tends to look different under examination from the spondyloarthropathy type. It is usually granulomatous, with large greasy-looking deposits on the back of the cornea, and it often affects both eyes. Posterior involvement can include inflammation in the vitreous, blood vessel inflammation in the retina, and choroidal lesions.6PubMed Central. Sarcoidosis-Related Uveitis: A Review
Diagnosis is tricky because the gold standard requires a biopsy showing non-caseating granulomas, and eye biopsies are technically difficult. In practice, clinicians often rely on a combination of clinical appearance, chest imaging showing typical lymph node enlargement, and blood tests. International diagnostic criteria have been developed and recently revised to help standardize the process. In children, sarcoidosis behaves differently from adults and is subdivided into early-onset forms that can begin before age five.7PubMed Central. Ocular sarcoidosis in adults and children: update on clinical manifestation and diagnosis
Behçet’s Disease
Behçet’s disease is a systemic vasculitis, meaning the immune system attacks blood vessels throughout the body. The eye involvement tends to be severe. Behçet’s uveitis typically presents as a chronic, relapsing, bilateral inflammation that can involve the entire eye, a pattern called panuveitis. Only about 10% of patients, mostly women, have isolated anterior inflammation. Occlusive necrotizing vasculitis of the retinal blood vessels is a hallmark feature and one of the main reasons Behçet’s carries a high risk of serious vision loss.8PubMed Central. Ocular Manifestations of Behçet’s Disease: An Update on Diagnostic Challenges and Disease Management
Despite advances in treatment, Behçet’s remains one of the most challenging forms of uveitis to manage. The disease relapses frequently, the inflammation is intense, and monitoring tools are limited. No single biomarker reliably tracks disease activity or predicts flares.9PubMed. International consensuses and guidelines on managing ocular Behçet’s disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI) Infliximab, a biologic drug that blocks tumor necrosis factor, has shown promise in patients who fail conventional immunosuppression with corticosteroids and drugs like cyclosporine or azathioprine.10PubMed. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease
Vogt-Koyanagi-Harada Disease
VKH disease targets melanocytes, the pigment-producing cells found in the skin, hair, inner ear, and the pigmented layer of the eye. The immune system attacks these cells, and the eye is often the first organ affected. Patients develop bilateral granulomatous uveitis, frequently with exudative retinal detachments, and many go on to develop skin depigmentation (vitiligo), whitening of the hair or eyelashes, hearing problems, and neurological symptoms like headaches or meningismus.11PubMed Central. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes
VKH is more common in people with darker pigmentation and in certain ethnic groups, particularly those of Asian, Hispanic, and Middle Eastern descent. The genetic susceptibility is linked to HLA-DRB1*0405, and the disease is thought to be triggered by a viral infection that primes the immune system against melanocyte proteins. Early, aggressive treatment with corticosteroids can often preserve vision, but chronic smoldering disease leads to complications including glaucoma, cataracts, and subretinal fibrosis.
Inflammatory Bowel Disease
Both Crohn’s disease and ulcerative colitis are associated with uveitis, though the relationship is sometimes overlooked because gut and eye symptoms can occur years apart. Uveitis is considered an extraintestinal manifestation of inflammatory bowel disease, and its presence often signals more severe systemic inflammation.12PubMed. Differences in the prevalence of uveitis between Crohn’s disease and ulcerative colitis: A systematic review and meta-analysis The uveitis in IBD can be anterior, intermediate, or posterior, and it shares the same genetic overlap with spondyloarthropathies noted above, reinforcing the idea that these conditions exist on a shared inflammatory spectrum.3PubMed Central. Recent Developments in HLA B27 Anterior Uveitis
Multiple Sclerosis
Multiple sclerosis is an autoimmune condition that attacks the myelin sheath around nerve fibers, but it also has a recognized association with uveitis. The most common pattern in MS patients is intermediate uveitis, where inflammation centers in the vitreous gel rather than the front of the eye. Patients tend to present with floaters and blurred vision rather than the redness and pain seen in anterior uveitis. Retinal vasculitis often accompanies the intermediate inflammation.13PubMed. Insights into multiple sclerosis-associated uveitis: a scoping review
Both MS and intermediate uveitis are linked to the same genetic variants, including HLA-DRB1*15:01, suggesting a shared susceptibility rather than a coincidental overlap.13PubMed. Insights into multiple sclerosis-associated uveitis: a scoping review The connection runs in both directions: a patient diagnosed with intermediate uveitis should be evaluated for demyelinating disease, and MS patients who develop visual symptoms beyond optic neuritis should be assessed for uveitis.
Less Common but Clinically Important Associations
Several other autoimmune diseases cause uveitis less frequently but are important to recognize because the eye inflammation can be the first clue to the diagnosis.
Granulomatosis with polyangiitis (formerly Wegener’s granulomatosis) is a vasculitis that affects small blood vessels and commonly involves the eye. Eye and orbital manifestations occur in close to half of GPA patients, affecting everything from the eyelids and orbit to the retina and optic nerve.14PubMed Central. Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature The most common eye findings are scleritis and orbital masses rather than uveitis itself, but uveitis and retinal vasculitis do occur.15PubMed. Wegener’s granulomatosis: ophthalmic manifestations and management
Tubulointerstitial nephritis and uveitis syndrome (TINU) is a condition where the immune system simultaneously attacks the kidneys and the eyes. It mainly affects adolescents and young adults, with a median age of around 17 years. About 80% of cases present as bilateral anterior uveitis. The kidney disease tends to improve within several months with corticosteroid treatment, but the uveitis can recur independently and persist for years.16PubMed Central. A Comprehensive Review of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome Fatigue, weight loss, and fever are common systemic symptoms.17Nephrology Dialysis Transplantation. Tubulointerstitial nephritis and uveitis syndrome: a systematic review
Systemic lupus erythematosus can cause retinal vasculitis, which sometimes appears before other lupus features are clinically obvious. While lupus-related eye disease is less common than joint or skin involvement, its presence during a flare signals active systemic disease and warrants aggressive management.18PubMed Central. Retinal vasculitis in systemic lupus erythematosus: an indication of active disease
Why the Eye Is Vulnerable to Autoimmune Attack
The eye is normally an immunologically privileged site. Healthy individuals carry circulating immune cells that could theoretically react against retinal proteins, but a series of physical and chemical barriers keeps those cells out.19Journal of Autoimmunity. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen The blood-retinal barrier functions much like the blood-brain barrier, tightly regulating what enters the interior of the eye.
In autoimmune uveitis, this barrier breaks down. Immune cells infiltrate the interior of the eye and trigger inflammation that can damage the delicate neural tissue of the retina.20PubMed Central. Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis Recent research has shown that systemic inflammatory arthritis alone can increase blood-retinal barrier permeability, even when there is no obvious eye disease. This sets the stage: if immune cells specifically targeting eye proteins are present, the compromised barrier lets them in more easily.21PubMed Central. Inflammatory arthritis disrupts ocular immune privilege by compromising blood-retinal barrier integrity and promoting uveitogenic T cell recruitment This helps explain why uveitis so often accompanies inflammatory diseases elsewhere in the body, particularly joint disease.
The Gut Microbiome Connection
An emerging area of research links changes in gut bacteria to the development of uveitis. Animal studies show that germ-free mice or those treated with broad-spectrum oral antibiotics develop less severe experimental uveitis, suggesting that gut bacteria play a role in priming the immune system toward eye inflammation.22PubMed Central. Uveitis and the gut microbiota
Several mechanisms have been proposed for how gut microbes might contribute. Molecular mimicry, where gut bacterial proteins resemble retinal proteins, could train immune cells to attack both. Alterations in the balance between regulatory and pro-inflammatory immune cells in the gut may spill over systemically. Increased intestinal permeability, sometimes called “leaky gut,” and the loss of beneficial microbial metabolites may also play a role.23PubMed. The Microbiome and Uveitis: A Narrative Review Proving causality in humans remains difficult, but the overlap between gut inflammation (as seen in inflammatory bowel disease) and uveitis lends weight to this line of investigation.
Drug-Induced Autoimmune Uveitis
Not all autoimmune uveitis arises from a pre-existing disease. Immune checkpoint inhibitors, which are cancer drugs that release the brakes on the immune system to help it fight tumors, can trigger uveitis as a side effect. As these drugs have become standard treatment for melanoma, lung cancer, and other malignancies, reports of uveitis following treatment have increased.24PubMed Central. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
A large population-based study found that the risk depends on the specific class of drug. Anti-PD-1 drugs carried about double the risk of uveitis compared to patients not on checkpoint inhibitors, and anti-CTLA-4 therapy carried a nearly six-fold increase. Anti-PD-L1 drugs, by contrast, did not show a statistically significant increase in risk.25Frontiers in Immunology. Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database For oncologists and ophthalmologists alike, recognizing this connection is essential because stopping or adjusting the cancer drug may be necessary to save vision, and that decision has to be weighed against cancer treatment goals.
Complications That Threaten Vision
Autoimmune uveitis is not just uncomfortable; it can be sight-threatening. In a study tracking adult uveitis patients over a median follow-up of about 16 months, over 40% developed at least one complication. The most common were cataract formation in about a quarter of patients, structural changes to the iris in about a fifth, and macular edema in roughly one in six.26PubMed. Risk factors for ocular complications in adult patients with uveitis
Macular edema, where fluid accumulates in the central part of the retina responsible for sharp vision, deserves special attention because it occurs across many of the autoimmune diseases discussed here, including Behçet’s disease, sarcoidosis, HLA-B27 spondyloarthritis, VKH, JIA, and inflammatory bowel disease.27PubMed Central. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges Glaucoma and permanent retinal scarring are additional risks with chronic or poorly controlled disease. These complications accumulate with each flare, which is why controlling the underlying autoimmune process is so critical for long-term visual outcomes.
Treatment Approaches
Corticosteroid eye drops are the first-line treatment for most acute uveitis episodes and work well for short flares. The problem is that many autoimmune forms of uveitis are chronic or frequently recurring, and long-term steroid use creates its own complications, particularly cataracts and glaucoma. When uveitis is tied to a systemic autoimmune disease, the goal shifts toward controlling the immune process with steroid-sparing drugs.
Traditional immunosuppressants like methotrexate, azathioprine, and mycophenolate have been used for years. In the past decade, biologic drugs have transformed the landscape. Adalimumab, a drug that blocks tumor necrosis factor, was the first biologic approved specifically for noninfectious uveitis. In a major trial, patients on adalimumab took nearly twice as long to experience treatment failure compared to placebo, and showed better outcomes in both anterior chamber inflammation and visual acuity.28PubMed. Adalimumab in Patients with Active Noninfectious Uveitis Adalimumab has proven especially useful in JIA-associated uveitis and sarcoidosis, while infliximab, a related biologic, has shown strong results in Behçet’s-related eye disease.29PubMed Central. The use of biologic therapies in uveitis In children with chronic uveitis that fails adalimumab, switching to infliximab has also produced significant reductions in eye inflammation.30PubMed Central. Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy
Pregnancy and Uveitis Activity
Women with autoimmune uveitis who are planning a pregnancy often worry about flares during or after gestation. The evidence is reassuring during pregnancy itself: noninfectious uveitis tends to quiet down starting in the second trimester, with the third trimester being the period of lowest disease activity.31PubMed Central. Uveitis and gender: the course of uveitis in pregnancy This pattern mirrors what is seen in other autoimmune conditions like rheumatoid arthritis and reflects the shift in the maternal immune system toward tolerance.
The catch is the postpartum period. Once hormone levels drop sharply after delivery, uveitis activity often rebounds.32PubMed Central. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis Women and their physicians need to plan for close eye monitoring in the weeks after birth, and treatment strategies should account for the likelihood of a flare at a time when medication choices are complicated by breastfeeding considerations.
Getting the Diagnosis Right
When a patient shows up with uveitis, identifying whether an autoimmune disease is behind it requires detective work. The appearance of the uveitis itself provides clues. Anterior uveitis in a young man suggests spondyloarthropathy. Silent bilateral anterior uveitis in a preschool-aged girl points toward JIA. Granulomatous inflammation with characteristic corneal deposits raises suspicion for sarcoidosis or VKH. Panuveitis with retinal vasculitis in a young adult from the Mediterranean, Middle East, or East Asia should prompt evaluation for Behçet’s disease.
Laboratory testing fills in the picture. Blood tests may include HLA-B27 typing, antinuclear antibodies, inflammatory markers, and disease-specific tests. Chest imaging is used to screen for sarcoidosis. The challenge is that no single test panel covers every possible autoimmune cause, and clinicians have to be guided by the clinical presentation. Intermediate uveitis, where the vitreous is the main site of inflammation, narrows the differential to conditions like sarcoidosis, MS, and a few infections, while the term “pars planitis” is reserved for the idiopathic subset with no identifiable systemic cause.33PubMed Central. Intermediate uveitis Getting the right diagnosis matters because treatment directed at the underlying disease is far more effective than treating each uveitis flare in isolation.